Preventing Mother-to-Child Transmission of HIV-1
Author Information
Author(s): Miroslaw K. Gorny, Susan Zolla-Pazner
Primary Institution: New York University School of Medicine
Hypothesis
Can human anti-HIV monoclonal antibodies be useful in preventing mother-to-child transmission of subtype C HIV viruses in South Africa?
Conclusion
The study concludes that two tested monoclonal antibodies should not proceed to clinical trials for preventing mother-to-child transmission of HIV-1 subtype C.
Supporting Evidence
- Passive immunization has shown protection against HIV-1 in animal models.
- Two of the tested monoclonal antibodies had no neutralizing activity against subtype C isolates.
- One clinical trial showed a trend toward lower transmission with HIVIG compared to control immunoglobulin.
Takeaway
The study looked at whether certain antibodies could help stop mothers from passing HIV to their babies, but found that some of them didn't work well.
Methodology
The study tested the neutralizing activity of four monoclonal antibodies against seven subtype C primary isolates from pediatric patients.
Potential Biases
Concerns about the autoreactive characteristics of some antibodies tested.
Limitations
The study's findings are limited by the low transmission rates observed in the clinical trial groups.
Participant Demographics
The study involved pediatric patients with subtype C HIV.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website